479 Total Number of Publications
 
Filter Publications:
Search Publications:

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins

Respiratory syncytial virus (RSV) is a major human pathogen that infects the majority of children by two years of age. The RSV fusion (F) protein is a primary target of human antibodies, and it has several antigenic regions capable of inducing neutralizing antibodies. Antigenic site IV is preserved in both…
Mousa, JJ;Binshtein, E;Human, S;Fong, RH;Alvarado, G;Doranz, BJ;Moore, ML;Ohi, MD;Crowe, JE;

PLoS Pathog.
View Publication

eIF2α phosphorylation is pathognomonic for immunogenic cell death

The phosphorylation of eIF2α is essential for the endoplasmic reticulum (ER) stress response, the formation of stress granules, as well as macroautophagy. Several successful anticancer chemotherapeutics have the property to induce immunogenic cell death (ICD), thereby causing anticancer immune responses. ICD is accompanied by the translocation of calreticulin (CALR) from…
Bezu, L;Sauvat, A;Humeau, J;Gomes-da-Silva, LC;Iribarren, K;Forveille, S;Garcia, P;Zhao, L;Liu, P;Zitvogel, L;Senovilla, L;Kepp, O;Kroemer, G;

Cell Death Differ.
View Publication

Development of a high throughput, bead-based flow cytometry panel for T-helper cell cytokine quantitation

For proof of concept studies, peripheral blood mononuclear cells (PBMCs) from 3 donors were cultured in media containing human sera and IL-2. Cells were stimulated with anti- CD3/CD28 beads and cytokine secretion was measured 1, 2, and 3 days post-stimulation. Donor to donor variation and temporal differences in secreted cytokine…
O’Rourke, J;Weldon, C;Carter, LK;

Journal of Immunology
View Publication

Empirical measures of mutational effects define neutral models of regulatory evolution in Saccharomyces cerevisiae

Understanding how phenotypes evolve requires disentangling the effects of mutation generating new variation from the effects of selection filtering it. Evolutionary models frequently assume that mutation introduces phenotypic variation symmetrically around the population mean, yet few studies have tested this assumption by deeply sampling the distributions of mutational effects for…
Hodgins-Davis, A;Duveau, F;Walker, EA;Wittkopp, PJ;

bioRxiv
View Publication

Functional characterization and lineage analysis of broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics

Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To delineate bNAb targets, we characterized 28 monoclonal antibodies belonging to expanded and hypermutated clonal families identified by transcriptomic analysis of single plasmablasts from DENV-infected…
Durham, ND;Agrawal, A;Waltari, E;Croote, D;Zanini, F;

bioRxiv
View Publication

Expediting Antibody Discovery with a Cell and Bead Multiplexed Competition Assay

With advances in molecular engineering and humanization, monoclonal antibodies are one of the fastest-growing classes of biopharmaceuticals. During antibody discovery, antibody from hybridoma or primary B-cell supernatants is screened for the desired binding characteristics, and secondary screens measure antibody function and concentration, identify immunoglobulin G (IgG) isotype, and assess cell…
Liu, Z;O'Rourke, J;

SLAS Discov
View Publication

Mxra8 is a receptor for multiple arthritogenic alphaviruses

Arthritogenic alphaviruses comprise a group of enveloped RNA viruses that are transmitted to humans by mosquitoes and cause debilitating acute and chronic musculoskeletal disease 1 . The host factors required for alphavirus entry remain poorly characterized 2 . Here we use a genome-wide CRISPR-Cas9-based screen to identify the cell adhesion…
Zhang, R;Kim, AS;Fox, JM;Nair, S;Basore, K;Klimstra, WB;Rimkunas, R;Fong, RH;Lin, H;Poddar, S;Crowe, JE;Doranz, BJ;Fremont, DH;Diamond, MS;

Nature
View Publication

High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen

Classical therapeutic regimens are subject to toxicity, low efficacy, and/or the development of drug resistance. Thus, the discovery of synergistic drug combinations would permit treatment with lower, tolerable dosages of each agent and restored sensitivity. We describe the development and use of the SynScreen software application, which allows for visual…
Perez, DR;Edwards, BS;Sklar, LA;Chigaev, A;

SLAS Discov
View Publication

Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective

Flow cytometry is a powerful tool providing multiparametric analysis of single cells or particles. The introduction of faster plate-based sampling technologies on flow cytometers has transformed the technology into one that has become attractive for higher throughput drug discovery screening. This article describes AstraZeneca's perspectives on the deployment and application…
Ding, M;Clark, R;Bardelle, C;Backmark, A;Norris, T;Williams, W;Wigglesworth, M;Howes, R;

SLAS Discov
View Publication

Flow Cytometry-Based Epitope Binning Using Competitive Binding Profiles for the Characterization of Monoclonal Antibodies against Cellular and Soluble Protein Targets

A key step in the therapeutic antibody drug discovery process is early identification of diverse candidate molecules. Information comparing antibody binding epitopes can be used to classify antibodies within a large panel, guiding rational lead molecule selection. We describe a novel epitope binning method utilizing high-throughput flow cytometry (HTFC) that…
Chan, BM;Badh, A;Berry, KA;Grauer, SA;King, CT;

SLAS Discov
View Publication